Entera Bio Ltd (ENTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 57 | 0 | 0 | 0 | 0 |
| Cost of Goods | 48 | N/A | N/A | N/A | N/A |
| Gross Profit | 9 | N/A | N/A | N/A | N/A |
| Operating Expenses | 2,222 | 2,062 | 1,963 | 2,386 | 2,330 |
| Operating Income | -2,165 | -2,062 | -1,963 | -2,386 | -2,330 |
| Other Income | 20 | 45 | -32 | 36 | 5 |
| Pre-tax Income | -2,145 | -2,017 | -1,995 | -2,350 | -2,325 |
| Income Tax | N/A | N/A | N/A | 29 | N/A |
| Net Income Continuous | -2,145 | -2,017 | -1,995 | -2,379 | -2,325 |
| Net Income | $-2,145 | $-2,017 | $-1,995 | $-2,379 | $-2,325 |
| EPS Basic Total Ops | -0.06 | -0.05 | -0.07 | -0.08 | -0.08 |
| EPS Basic Continuous Ops | -0.06 | -0.05 | -0.07 | -0.08 | -0.08 |
| EPS Diluted Total Ops | -0.06 | -0.05 | -0.07 | -0.08 | -0.08 |
| EPS Diluted Continuous Ops | -0.06 | -0.05 | -0.07 | -0.08 | -0.08 |
| EPS Diluted Before Non-Recurring Items | -0.06 | -0.05 | -0.07 | N/A | N/A |
| EBITDA(a) | $-2,154 | $-2,049 | $-1,950 | $-2,372 | $-2,315 |